Aortic Dimensions in Patients With Fabry Disease
- Sponsor
- University Hospital, Caen
- Study ID
- NCT06956573
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- aorta imaging — OTHERRetrospective analysis of imaging data (echocardiography and/or cardiac MRI) in adult patients with Fabry disease to assess ascending aortic diameters.
Study Details
We will conduct a retrospective study aiming to define the characteristics, determinants, and progression of ascending aortic dilatation in adults with Fabry disease, using echocardiography and/or cardiac MRI
Key Dates
- Start date
- May 2, 2025
- Status verified
- Apr 2025
- Primary completion
- May 2, 2025
- Completion
- May 2, 2026
Study Design
- Enrollment
- 200 participants (estimated)
Primary Outcome Measure
Maximum ascending aortic diameter measured by transthoracic echocardiography or cardiac MRI, expressed as a Z-score. [ Time Frame: At baseline ]
Related Studies
- Fabry Disease Registry & Pregnancy Sub-registryRecruiting · Genzyme, a Sanofi Company · Birmingham, Alabama
- Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease StudyRecruiting · University of Minnesota · Minneapolis, Minnesota
- A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and BreastfeedingRecruiting · Amicus Therapeutics · Philadelphia, Pennsylvania
- Long-Term Follow-up of Subjects Who Were Treated With ST-920Enrolling By Invitation · Sangamo Therapeutics · Irvine, California